Protagonist Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts that cover Protagonist Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $100.64, which forecasts a 9.30% increase in the stock price over the next year. The lowest target is $73 and the highest is $118.

Price Target: $100.64 (+9.30%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$73	$100.64	$110	$118
Change	-20.72%	+9.30%	+19.46%	+28.15%

Analyst Ratings

The average analyst rating for Protagonist Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	4	4	4	4	4	6
Buy	5	5	5	5	5	5
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tara Bancroft TD Cowen	TD Cowen	Strong Buy Maintains $90 → $100	Strong Buy	Maintains	$90 → $100	+8.60%	Feb 26, 2026
Etzer Darout Barclays	Barclays	Buy Maintains $108 → $113	Buy	Maintains	$108 → $113	+22.72%	Feb 26, 2026
Jonathan Wolleben Citizens	Citizens	Buy Maintains $102 → $112	Buy	Maintains	$102 → $112	+21.63%	Feb 26, 2026
Roger Song Jefferies	Jefferies	Strong Buy Maintains $95 → $118	Strong Buy	Maintains	$95 → $118	+28.15%	Feb 2, 2026
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $80 → $117	Strong Buy	Maintains	$80 → $117	+27.06%	Jan 30, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

312.17M

from 46.02M

578.39%

from 46.02M

Revenue Next Year

136.47M

from 312.17M

-56.28%

from 312.17M

EPS This Year

0.37

from -2.05

EPS Next Year

-1.33

from 0.37

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	27.36M	26.58M	60.00M	434.43M	46.02M	312.17M	136.47M
Revenue Growth	-4.44%	-2.84%	125.73%	624.06%	-89.41%	578.39%	-56.28%
EPS	-2.71	-2.60	-1.39	4.23	-2.05	0.37	-1.33
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	246.80	-
No. Analysts	-	-	-	-	-	15	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	588.5M	282.4M
Avg	312.2M	136.5M
Low	19.6M	39.1M

Revenue Growth

Revenue Growth	2026	2027
High	1,179.0%	-9.5%
Avg	578.4%	-56.3%
Low	-57.4%	-87.5%

EPS Forecast

EPS	2026	2027
High	5.29	0.11
Avg	0.37	-1.33
Low	-2.31	-2.09

EPS Growth

EPS Growth	2026	2027
High	-	-71.9%
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.